← Evidence map

ArticleClinical parkinsonism & related disorders2023

Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson's disease.

Noriyuki Miyaue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38021340